Clot Retraction

• 

  Subject Areas on Research

  • Comparison of streptokinase, urokinase, and recombinant tissue plasminogen activator in an in vitro model of venous thrombolysis. 
  • Individual lytic efficacy of recombinant tissue plasminogen activator in an in vitro human clot model: rate of "nonresponse". 
  • Intra-arterial therapies for acute ischemic stroke: unsafe and without proven value. 
  • Nanosilver composite pNIPAm microgels for the development of antimicrobial platelet-like particles. 
  • The effects of platelet count on clot retraction and tissue plasminogen activator-induced fibrinolysis on thrombelastography.